There are many current studies on coronavirus, each with its own purpose, but the goal is the same: Researchers are still trying to learn as much as they can about COVID-19.
So, let’s take a look at a few of the most recent studies on coronavirus that have been making the news.
Researchers at Oslo University Hospital analyzed the genomes of roughly 4,000 people from Italy and Spain: 1,980 people with COVID-19 who developed respiratory failure and more than 2,000 people who did not have the disease.
They found that people with blood Type A-positive had an increased risk of lung failure compared with those with other blood types, whereas those with Type O blood were protected to some extent. But more research is needed.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring and funding the HEROS study. This team of researchers is studying 6,000 people from 2,000 families in the United States.
Study participants include both healthy children and children with asthma or other allergic conditions. The children and their families will be followed for six months to determine who gets infected with SARS-CoV-2, whether the virus is transmitted to other family members, and which family members with the virus develop COVID-19.
Preliminary evidence suggests that having an allergic condition paradoxically may reduce a person’s susceptibility to SARS-CoV-2 infection and severe COVID-19 disease.
Two papers relying on hospital records of COVID-19 patients have been retracted because the company that purportedly analyzed the raw data won’t allow their validity to be independently confirmed. The studies were retracted by the scientific journals in which they had appeared, The New England Journal of Medicine and The Lancet.
The Lancet study found hydroxychloroquine increased the risk of death in COVID-19 patients,
According to The New York Times “The retractions may breathe new life into the antimalarial drugs hydroxychloroquine and chloroquine, as a remedy for Covid-19 despite a lack of evidence. After the journals noted concerns about the studies, the World Health Organization announced that it would resume trials of the medications.”
The other study found that some blood pressure drugs did not increase the risk of COVID-19 and might even be protective, but was retracted by The New England Journal of Medicine because of a lack of validated evidence, so more studies will be needed.
The World Health Organization’s website provides a list of research journals that you can use to track the latest studies on coronavirus.
You can also talk to your doctor about the latest research on the COVID-19 pandemic and any public health issues it poses. We’re taking a number of precautionary measures in all of our office buildings to ensure you’re walking into a facility that is safe. But if you’re still unsure about an in-person visit, you can set up a telehealth appointment.
If you’d like to stay ahead of your health, a good way to do it is by getting regular health screenings. We have a checklist to help you keep track. The “Midlife Health Screenings” guide can let you know what tests you need and when you need them.